Journal
NATURE GENETICS
Volume 40, Issue 1, Pages 43-50Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2007.30
Keywords
-
Categories
Funding
- NATIONAL CANCER INSTITUTE [R01CA102709, R01CA120185, R01CA122334] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA102709-01, R01 CA122334-01A1, R01 CA102709-02, R01 CA120185, R01 CA102709, R01 CA102709-03, R01 CA122334, R01 CA102709-04, R01 CA122334-02] Funding Source: Medline
Ask authors/readers for more resources
The c-Myc oncogenic transcription factor (Myc) is pathologically activated in many human malignancies. Myc is known to directly upregulate a pro-tumorigenic group of microRNAs (miRNAs) known as the miR-17 - 92 cluster. Through the analysis of human and mouse models of B cell lymphoma, we show here that Myc regulates a much broader set of miRNAs than previously anticipated. Unexpectedly, the predominant consequence of activation of Myc is widespread repression of miRNA expression. Chromatin immunoprecipitation reveals that much of this repression is likely to be a direct result of Myc binding to miRNA promoters. We further show that enforced expression of repressed miRNAs diminishes the tumorigenic potential of lymphoma cells. These results demonstrate that extensive reprogramming of the miRNA transcriptome by Myc contributes to tumorigenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available